Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00617201 · ClinicalTrials.gov registry record · Phase 2

Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial

A Phase 2 study of Substance Abuse, sponsored by Sharon Walsh.

Completed
Registry status
Phase 2
Development phase
50
Enrollment target
1
Study location

NCT00617201 is a Phase 2 study of Substance Abuse that has completed, run by Sharon Walsh. The registered enrollment target is 50 participants, below the 5,259-participant average among 58 other Substance Abuse trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00617201, a Phase 2 study of Substance Abuse, has completed, sponsored by Sharon Walsh.

COMPLETED
Registry status
Phase 2
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This placebo-controlled, double-blind, randomized pilot clinical trial will evaluate atomoxetine (Strattera®) for the treatment of cocaine dependence. Cocaine-dependent individuals, who are healthy and are seeking treatment for their substance abuse, will be randomized to receive either atomoxetine (n=25) or a matched-placebo (n=25) during a trial lasting 12 weeks; there will be a double-blind, ascending dose lead-in order to achieve maintenance on the assigned active dose safely. Contingency management procedures will be used to reinforce attendance and compliance with study procedures. Primary outcome measures will include urinalysis data assessing cocaine use.

Conditions Studied

Substance Abuse

Interventions

  • DRUG placebo
  • DRUG atomoxetine

Study Locations (1)

Kentucky

  • Straus Research Building - Lexington

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2007-07
Est. Completion 2011-08
Phase Phase 2

Sponsor

Sharon Walsh

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00617201

The ClinicalTrials.gov registry entry for NCT00617201 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,259-participant average among 58 other Substance Abuse trials with a reported enrollment target (99% lower). The listed sponsor is Sharon Walsh, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Substance Abuse appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT00617201 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT00617201 about?

NCT00617201 is a clinical study titled "Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial". This placebo-controlled, double-blind, randomized pilot clinical trial will evaluate atomoxetine (Strattera®) for the treatment of cocaine dependence. Cocaine-dependent individuals, who are healthy and are seeking treatment for their substance abuse, will be randomized to receive either atomoxetine ...

What is the current status of trial NCT00617201?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2007-07. Estimated completion is 2011-08.

What conditions does trial NCT00617201 study?

This clinical trial studies the following conditions: Substance Abuse.

What interventions are being tested in trial NCT00617201?

The interventions under investigation include: placebo (DRUG), atomoxetine (DRUG).

Who is sponsoring clinical trial NCT00617201?

This trial is sponsored by Sharon Walsh, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00617201 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Substance Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Substance Abuse

All registered trials for this condition

Kentucky

All trials with a study site in Kentucky

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.